Picture of Zimmer Biomet Holdings logo

ZBH Zimmer Biomet Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Zimmer Biomet Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,813-3791,132-137402
Depreciation
Deferred Taxes
Non-Cash Items4181,045154725267
Unusual Items
Other Non-Cash Items
Changes in Working Capital64.227.6-168-428-87.3
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities1,5821,7471,5861,2051,499
Capital Expenditures-493-439-721-410-482
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-17.822.4-8.7-204-21.4
Acquisition of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-511-417-729-614-504
Financing Cash Flow Items85.8-60.5-25.3-100-173
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,211-1,302-780-422-1,306
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-11018.475.1184-324

Or unlock with your email

Or unlock with your email